This compound is a protected intermediate used in the manufacturing of the antiviral pharmaceutical ingredient acyclovir. It features a tert-butyl carbamate protecting group and a 2-hydroxyethoxymethyl side chain, which are key structural elements for subsequent synthesis steps.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
N2-acetylaciclovir
pharmaceutical raw material
(3S,4R)-3-ethyl-4-(3-tosyl-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
pharmaceutical intermediate
N-desmethyl afatinib
pharmaceutical intermediate
(R)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((R)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)-3-hydroxybutanamide
pharmaceutical intermediate
Afatinib Impurity 18
pharmaceutical intermediate
tert-butyl N-[9-(2-hydroxyethoxymethyl)-6-oxo-1H-purin-2-yl]carbamate
PSEXLVZZRHZDKD-UHFFFAOYSA-N
CC(C)(C)OC(=O)NC1=NC2=C(C(=O)N1)N=CN2COCCO
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.